BioMarin

+$0.67 (+0.87%) As of 7:07 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioMarin and other ETFs, options, and stocks.

About BMRN

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307.

CEO
Jean-Jacques Bienaimé
Employees
3,059
Headquarters
San Rafael, California
Founded
1997

BMRN Key Statistics

Market Cap
14.19B
Price-Earnings Ratio
18.12
Dividend Yield
—
Average Volume
1.05M
High Today
$77.74
Low Today
$76.50
Open Price
$76.69
Volume
544.33K
52 Week High
$124.52
52 Week Low
$71.35

BMRN News

BenzingaJul 28

Biomarin Pharmaceutical: Q2 Earnings Insights

Shares of Biomarin Pharmaceutical (NASDAQ:BMRN) were flat in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share

BMRN Earnings

-$0.19
$1.21
$2.61
$4.01
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
-$0.11 per share
Actual
$0.07 per share
Replay Earnings Call
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure